netFormulary
 Report : A-Z NHS England items in Formulary 18/02/2020 00:44:20
[Back]
 
Section Status NHS England Name
08.02.04 Restricted Use MHS England Beta-interferon-1a Avonex
08.02.04 Restricted Use MHS England Beta-interferon-1b Extavia
08.02.04 Restricted Use MHS England Beta-interferon-1b Betaferon
08.02.04 Restricted Use MHS England Cladribine Mavenclad
05.03.01 Restricted Use MHS England Cobicistat  
05.03.03 Restricted Use MHS England Daclatasvir  
05.03.01 Formulary MHS England Darunavir, Cobicistat, Emtricitabine and tenofovir alafenamide Symtuza
05.03.03 Restricted Use MHS England Dasabuvir  
05.03.01 Restricted Use MHS England Dolutegravir & lamivudine Dovato
03.07 Restricted Use MHS England Dornase Alfa Pulmozyme
05.03.03 Restricted Use MHS England Elbasvir and grazoprevir Zepatier
04.08.01 Formulary MHS England Everolimus Votubia
08.02.04 Restricted Use MHS England Fingolimod Gilyena
08.02.04 Restricted Use MHS England Glatiramer Acetate 
08.02.04 Restricted Use MHS England Interferon beta 
08.02.04 Formulary MHS England Interferon beta-1a Rebif
03.07 Restricted Use MHS England Ivacaftor  
05.03.03 Restricted Use MHS England Ledipasvir and sofosbuvir  Harvoni
02.12 Formulary MHS England Lomitapide Lojuxta
03.07 Restricted Use MHS England Lumacaftor/ Ivacaftor  Orkambi
03.07 Restricted Use MHS England Mannitol  
08.02.04 Restricted Use MHS England Natalizumab  Tysabri
14.05 Restricted Use MHS England Normal Immunoglobulin  Octagam 10%
14.05 Restricted Use MHS England Normal Immunoglobulin  Privigen
14.05 Restricted Use MHS England Normal Immunoglobulin  Gamunex
14.05 Restricted Use MHS England Normal Immunoglobulin IQYMUNE
08.02.04 Restricted Use MHS England Ocrelizumab Ocrevus
05.03.03 Restricted Use MHS England Ombitasvir, paritaprevir, and ritonavir  Viekirax
05.03.05 Restricted Use MHS England Palivizumab Synagis
03.11 Restricted Use MHS England Pirfenidone  
05.03.03 Restricted Use MHS England Simeprevir 
05.03.03 Restricted Use MHS England Sofosbuvir 
05.03.03 Restricted Use MHS England Sofosbuvir, velpatasvir, voxilaprevir Vosevi
05.03.03 Restricted Use MHS England Sofosbuvir/valpatasvir Epclusa
05.03.03 Restricted Use MHS England Telaprevir 
03.07 Restricted Use MHS England Tezacaftor/ Ivacaftor Symkevi
Leicestershire Health Community